Literature DB >> 11125923

Prevention of congenital toxoplasmosis.

W Foulon1, A Naessens, D Ho-Yen.   

Abstract

In utero infection with Toxoplasma gondii may result in congenital defects such as hydrocephalus, chorioretinitis and mental retardation; these defects may be present at birth or may develop later in life. Prevention of this disease can be achieved in different ways. The most effective measure is to prevent the acquisition of the disease during pregnancy by avoiding risk factors for Toxoplasma gondii infection. Health education may decrease the incidence of toxoplasmosis during pregnancy by 60%. A second preventive measure is based on serologic screening during pregnancy to identify infected women. Treatment during pregnancy results in a significant reduction in the incidence of sequelae including severe handicaps. A third possible intervention is treating infected neonates. Antibiotic treatment of infected children has a beneficial effect on the development of sequelae and the sooner therapy is started after birth, the better the outcome. This overview presents the potential benefits and harms of these different options available for the prevention of congenital toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125923     DOI: 10.1515/JPM.2000.043

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  7 in total

1.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

2.  Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Adel Almogren
Journal:  Ann Saudi Med       Date:  2011 Nov-Dec       Impact factor: 1.526

3.  Changes in awareness and knowledge concerning mother-to-child infections among Japanese pregnant women between 2012 and 2018.

Authors:  Shutaro Suga; Kazumichi Fujioka; Ruka Nakasone; Shinya Abe; Sachiyo Fukushima; Mariko Ashina; Kosuke Nishida; Kandai Nozu; Kazumoto Iijima; Kenji Tanimura; Hideto Yamada
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

4.  Seroprevalence of Toxoplasma gondii infection among babies in Jeddah Province, Saudi Arabia: a retrospective study.

Authors:  Raafat Abdel Moneim Hassanein; Adel Galal El-Shemi; Mohammed Othman Alkurbi; Ameer Ahmed Alahmadi; Waslallah Saad Almatery
Journal:  Pan Afr Med J       Date:  2022-05-26

Review 5.  Prenatal education for congenital toxoplasmosis.

Authors:  Simona Di Mario; Vittorio Basevi; Carlo Gagliotti; Daniela Spettoli; Gianfranco Gori; Roberto D'Amico; Nicola Magrini
Journal:  Cochrane Database Syst Rev       Date:  2015-10-23

6.  Neglected parasitic infections in the United States: toxoplasmosis.

Authors:  Jeffrey L Jones; Monica E Parise; Anthony E Fiore
Journal:  Am J Trop Med Hyg       Date:  2014-05       Impact factor: 2.345

7.  Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014.

Authors:  Marcos Gontijo da Silva; Marina Clare Vinaud; Ana Maria de Castro
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.